Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Kia Nobre (Department of Experimental Psychology) and Professor Fiona Powrie (Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences) are two of 120 new members and 26 new international members newly elected to the National Academy of Sciences in recognition of their distinguished and continuing achievements in original research.

Professor Fiona Powrie (left), Professor Kia Nobre (right)

Professor Fiona Powrie, Director of the Kennedy Institute, Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences (NDORMS) was recognised for her outstanding contributions to immunology, and her election brings the number of current National Academy of Sciences members from the Kennedy Institute to three.

Professor Kia Nobre is the Chair of the Oxford Neuroscience Strategy Committee, Head of the Department of Experimental Psychology and Director of the Oxford Centre for Human Brain Activity

Read more about Fiona Powrie's election (NDORMS website)

Read more about Kia Nobre's election (Department of Experimental Psychology website)

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.